OSR #1 Update
On 18 June 2010, the FDA wrote to CTI Science questioning whether OSR#1® fit within the agency’s definition of a dietary supplement, indicating that instead it appeared to be a drug. Although we believe the product meets the legal definition of a “dietary supplement,” we have decided not to contest this point but to work with the agency. While achieving formal drug approval is lengthy and costly, CTI Science will in the course of it prove to FDA’s satisfaction the safety and efficacy of OSR#1® and ultimately be able to offer OSR#1® to the public with FDA-authorized therapeutic claims.
As a result of this decision, CTI Science has
voluntarily agreed to remove OSR#1® from the market effective Thursday, 29 July
2010. The product will not be available for sale after that date until new
drug approval has been obtained. Please access the CTI Science website,
updates on OSR#1® in the future.
Welcome to BrainworX
BrainworX is a comprehensive brain-based rehabilitation program that targets neurological deficiencies that have been identified with AD/HD, dyslexia, autism and other pediatric neuro-developmental disorders. Our evaluation involves lab testing for nutritional deficiencies, genetic mutations, metabolic disorders, postural assessment, balance and coordination testing, auditory and visual processing speed assessment, and gross/fine motor planning and sequencing evaluation. At BrainworX we use a multi-modal treatment approach to activate and retrain underdeveloped areas of the brain.